21 CFR 1.1410
§ 1.1410 When will FDA consider whether to waive a requirement of this subpart?
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 1.1410, § 1.1410 When will FDA consider whether to waive a requirement of this subpart?, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/82966
- Permanent ID
ys:prov:82966@1- SHA-256
6e8fb48b86e57f35978bb91b0ddc467366fbeec0617f01961619fe88fbd18219
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
FDA will consider whether to waive a requirement of this subpart on our own initiative or in response to the following:
(a) A written request for a waiver for an individual entity; or
(b) A citizen petition requesting a waiver for a type of entity submitted under § 10.30 of this chapter by any person subject to the requirements of this subpart.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.